Our Mission and Vision

Our mission is to discover new ways to improve and extend people’s lives.

We use science-based innovation to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to provide a shareholder return that rewards those who invest their money, time and ideas in our company.

Our Values

Strong values define our culture and help us execute the Novartis strategy in line with our mission and vision.

We have introduced Values and Behaviors that describe the professional behaviors we expect from our employees. These values were selected by the Executive Committee of Novartis – with input from associates worldwide – and form an integral part of the framework we use to recruit people, develop them and assess and reward their performance. We will hold ourselves to account against these values and behaviors.

These values and behaviors are:


by experimenting and delivering solutions


by taking pride in doing ordinary things extraordinarily well


by championing high performing teams with diversity and inclusion


by prioritizing and making things happen with urgency


by speaking up, giving and receiving feedback


by advocating and applying high ethical standards every day

Our Strategy

We believe Novartis is well prepared for a world with a growing, aging population and continuously evolving healthcare needs. We have a clear mission, focused strategy and strong culture, all of which we expect will support the creation of value over the long term for our company, our shareholders and society.

Our strategy is to use science-based innovation to deliver better patient outcomes. We aim to lead in growing areas of healthcare.

Science-based innovation

We believe innovation that produces breakthrough medicines and products will be more important than ever in the healthcare industry in the coming years. We maintain substantial investment in research and de­­velopment (R&D) aimed at areas of unmet medical needs. Our product pipeline is fed by a distinctive research and clinical approach that focuses on scientific advances before market ­potential.

Our R&D strategy is to continue ­reinforcing therapeutic areas where we are already strong – including oncology, cardiovascular, eye care, biosimilars and neuroscience – and to expand into new disease areas that we believe are ripe for innovation, such as immuno-­oncology, aging and regenerative medicine, and infectious diseases.

Better patient outcomes

We seek to develop medicines and products that can produce positive real-world outcomes for patients and healthcare providers. The benefits can range from improving the cost-­effectiveness of high-quality care to pro­longing lives. We are developing services and technol­o­gies to augment the benefits of our core products, often in collaboration with healthcare providers and technology companies.

Lead in growing areas of healthcare

We aim to develop innovative products in growing areas of healthcare where we can make a real difference. We focus on patented medicines, generic medicines and eye care – segments where we have the innovation power and global scale necessary to compete effectively. At the same time, we are expanding our presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high- quality medicines and healthcare.

Content provided by Novartis, Info Edge India Limited disclaims all warranties against infringement.
Visit Security Guidelines and Terms and conditions for more comprehensive information in this regard.